# A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain

> **NCT03176199** · PHASE4 · COMPLETED · sponsor: **Taiwan Mundipharma Pharmaceuticals Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Cancer
- Pain

## Interventions

- **DRUG:** Oxycodone
- **DRUG:** Oxycodone

## Key facts

- **NCT ID:** NCT03176199
- **Lead sponsor:** Taiwan Mundipharma Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03176199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03176199, "A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03176199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*